# Every scientist’s qPCR analyzed one way, and on record

> qPCR analysis for discovery and preclinical R&D: a settings set your team shares on a paid plan, saved reports that never change. Research use, not GxP.

Source: https://clarida.bio/for/pharma-biotech
Updated: 2026-10-29

[For pharma and biotech R&D](https://clarida.bio/for)

Each experiment starts from your lab’s settings, and its saved report never changes. From co-authors of MIQE and the people behind geNorm and qbase+.

[Talk to a founder](https://clarida.bio/talk-to-us?topic=demo) · [For your QA and IT](https://clarida.bio/for/pharma-biotech#for-your-qa-and-it)

Clarida is research-use software for discovery and preclinical R&D, not a validated GxP system: it has no electronic signatures and no Part 11 or Annex 11 controls. What it records about each analysis is listed [for your QA and IT](https://clarida.bio/for/pharma-biotech#for-your-qa-and-it), and whether it fits a study is your QA’s call.

## How a fold change reaches the program team

In discovery and preclinical work the analysis usually stays with the scientist who ran the plate: Cq exported to Excel, a ΔΔCq template or an R script, a geNorm check when the assay was first set up, the figure in Prism. It is quick, it stays in-house, and on one model it holds.

It gets harder once the work moves on. A new cell line or treatment can unsettle the reference genes: hypoxia made GAPDH and PGK1 unsuitable in four breast cancer cell lines ([Malcolm et al., 2025](https://doi.org/10.1186/s12864-025-11216-6)). The number on a review slide is rebuilt months later, from a script that has changed since, by someone who was not there. Your team checks outside findings for the same reason: Amgen’s scientists confirmed 6 of 53 landmark cancer studies they tried to reproduce ([Begley and Ellis, 2012](https://doi.org/10.1038/483531a)).

| Today | With Clarida |
| --- | --- |
| Each scientist’s own template or script | Every experiment begins from the lab’s settings set and records which version that was |
| Reference genes checked once, in the first model | geNorm and NormFinder score the candidates again in each experiment, on the model it ran |
| Dose groups over several plates, each normalized alone | Inter-run calibration ties the plates of one experiment together through the samples they share |
| A slide’s fold change rebuilt from today’s script | The saved report still shows it, with its settings and the Clarida release that made it |

Analyzing in R today? [When is your own script the better choice?](https://clarida.bio/compare/scripts#when)

## Four questions before a program acts on it

When a number goes to the program team, a partner site or QA, the same questions follow it. Clarida keeps each answer with the experiment.

Figure 1: One experiment’s record: the run, a well excluded by hand, with its note, and the report the program team saw in September, still as it was beside October’s version. Illustrative dates.

- **Which settings made it?** The experiment keeps the version of the lab’s [settings set](https://clarida.bio/methods/settings-sets) it started from, and the report names it in its methods. Changing the set makes a new version; experiments already under way keep theirs.
- **Was that well left out by a person, or by a rule?** Each exclusion shows which, with any note typed for it, and none made by hand is undone automatically ([Analyze](https://clarida.bio/qpcr/analyze#exclusion)).
- **Is this the number we saw in September?** A saved report cannot be changed: a later edit becomes its next version. Each one states who saved it, when, the Clarida release and a fingerprint of its input data ([Report](https://clarida.bio/qpcr/report#saved-reports)).
- **Can another site redo it?** Send the RDML file with the raw curves, and the report whose methods state the normalization, the test and the settings set used.

## Bring the assays you already run

- **Run files and Cq tables.** CFX, LightCycler 480, QuantStudio, Rotor-Gene or RDML, raw curves included, or a Cq table from any instrument. The instrument’s Cq stays beside the one Clarida calls from the curves ([importing instrument data](https://clarida.bio/methods/importing-instrument-data)).
- **A look before any company data goes in.** A new account opens with a demo experiment, so you can work through an analysis first.
- **One assay as the lab’s standard.** Save how your lab analyzes it as a settings set inside a [preset](https://clarida.bio/methods/presets), and the next scientist starts there.
- **qbase+ archives.** They [import free](https://clarida.bio/qbase-plus/import), read-only and outside your experiment count.

## For your QA and IT

What QA, IT and purchasing will ask before Clarida goes on the approved list.

- **What it is**: Research-use qPCR analysis software. Not a validated GxP system: no electronic signatures, no Part 11 or Annex 11 controls. Keep regulated studies in a validated system.
- **What it records**: For each experiment, the settings set version it began with. For each exclusion, whether a person or a rule made it, and any note typed for it. For each saved version, who and when. Saved reports are frozen and carry their author, time, release and input fingerprint. Not a log of every edit.
- **What it costs**: Per experiment at the commercial rate, never per seat. The rates and a calculator for your volume are on [pricing](https://clarida.bio/pricing?audience=commercial&billing=annual).
- **Where the data lives**: In the EU: the app runs in Amsterdam, the database in Stockholm, and everything travels over HTTPS.
- **Who sees it**: The people invited into the workspace. The organization’s owner belongs to each one it adds.
- **Signing in**: With Google, Microsoft or a code sent by email. SAML single sign-on is not built in yet; it is set up on request for a Center account. No enforced two-factor yet.
- **Certifications and contracts**: No SOC 2 or ISO 27001 certification yet. A data processing agreement, and the list of companies that host or handle your data, on request.
- **Getting it out**: One experiment at a time, as RDML, an Excel workbook or its report, whenever you like. There is no bulk export yet.
- **If you stop paying**: Your experiments stay viewable and exportable, but you cannot create new ones.
- **When Clarida changes**: Every change that can move a number is listed in the [release notes](https://clarida.bio/changelog/2026-10). Saved analyses and reports stay as they were; an experiment takes up a new calculation when it is next opened.
- **Who built it**: The people behind qbase+, building qPCR analysis software since 2007. Jan Hellemans led the qBase paper, Jo Vandesompele the geNorm one, and both co-wrote the MIQE guidelines ([meet them](https://clarida.bio/about)).
- **Not yet**: Electronic signatures, a read-only reviewer role, absolute quantification and dPCR. An audit trail of every edit is not built in yet; it is set up on request for a Center account.

## Frequently asked questions

### Does QA need to validate Clarida first?

That depends on what you use it for, and your QA decides. Outside regulated studies it is a research tool, like a spreadsheet or Prism. GLP and GMP studies belong in a validated system, since Clarida has no electronic signatures or Part 11 controls.

### Can Clarida run in a dedicated environment?

Not today. It runs as one service hosted in the EU, and each workspace is closed to everyone who is not a member. If your review requires your own environment, tell us what it asks for.

### Your scripts already work. Why change?

If every scientist runs them the same way and they show how each number was made, keep them. Clarida earns its place where each person’s copy has drifted, or the script is rebuilt by hand whenever the model changes.

### Can several groups work without seeing each other’s data?

Yes, on the Center plan: each group has its own workspace, and all of them draw on one account’s experiment allowance. The account’s owner is a member of each. Every group sets up its own settings set, because sets do not copy between workspaces.

### Does it do dPCR?

Not yet: analysis today is qPCR and RT-qPCR. If your work needs dPCR too, tell us.

Updated October 29, 2026

## Set up one assay the way your team runs it

We build it with you as a preset, so the next scientist on your team starts from it.

[Talk to a founder](https://clarida.bio/talk-to-us?topic=demo)
